Log In
BCIQ
Print this Print this
 

ANA380, LB80380

  Manage Alerts
Collapse Summary General Information
Company LG Life Sciences Ltd.
DescriptionNucleotide analog viral polymerase inhibitor
Molecular Target Viral polymerase
Mechanism of ActionDNA polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat chronic hepatitis B virus (HBV) infection; Treat chronic lamivudine-resistant hepatitis B virus (HBV) infection; Treat lamivudine-resistant hepatitis B virus (HBV) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today